Upadacitinib Is Safe and Effective in Older Adults: A Real-World Experience Comparing Safety and Efficacy in Younger Versus Older Adults with Inflammatory Bowel Disease.

PURPOSE: Upadacitinib (UPA), a selective Janus kinase (JAK) inhibitor, is a small molecule approved for the treatment of ulcerative colitis (UC) and Crohn's disease (CD) with limited data in the older adult population. We compared the safety and effi…

Preview only. Read the full abstract at the source